Aldo M. Roccaro - Concepedia

Author

Aldo M. Roccaro

Also Known As

A M Roccaro, A Roccaro, A. M. Roccaro, A. Roccaro, A.M. Roccaro, Aldo M Roccaro, Aldo M. Roccaro, Aldo Maria Roccaro, Aldo Roccaro, Aldo. M. Roccaro

522

Publications

12.6K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia University of Brescia Massachusetts General Hospital

About

Aldo M. Roccaro is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1.4K
2	Cell Biology	15	16	879
3	Health Sciences	9	9	342
4	Natural Sciences	2	2	86
5	Allergy	1	1	49

Aldo M. Roccaro

110

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression Aldo M. Roccaro, Antonio Sacco, Patricia Maiso, Journal of Clinical Investigation	2013	778
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy Abdel Kareem Azab, Judith Runnels, Costas Pitsillides, Blood	2009	419
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma Aldo M. Roccaro, Antonio Sacco, Brian Thompson, Blood	2009	309
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features Abdel Kareem Azab, Jinsong Hu, Phong Quang, Blood	2012	296
Bortezomib Mediates Antiangiogenesis in Multiple Myeloma via Direct and Indirect Effects on Endothelial Cells Aldo M. Roccaro, Teru Hideshima, Noopur Raje, Cancer Research	2006	284
Engineered nanomedicine for myeloma and bone microenvironment targeting Archana Swami, Michaela R. Reagan, Pamela A. Basto, Proceedings of the National Academy of Sciences	2014	280
Prognostic role of circulating exosomal miRNAs in multiple myeloma Salomon Manier, Chia‐Jen Liu, Hervé Avet‐Loiseau, Blood	2017	265
Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma Patricia Maiso, Daisy Huynh, Michele Moschetta, Cancer Research Metabolic RemodelingCancer BiologyTumor BiologyDrug ResistanceHematological Malignancy	2015	206
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma Aldo M. Roccaro, Antonio Sacco, Cristina Jiménez, Blood	2014	200
Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenström Macroglobulinemia Treated With Nucleoside Analogs Xavier Leleu, Jacob D. Soumerai, Aldo M. Roccaro, Journal of Clinical Oncology	2008	182

Page 1